Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Wall Street's Influence Over Medicine Is Costing Patients Their Lives, Says Florida Trial Lawyer Sean C. Domnick

      Logo: Rafferty Domnick Cunningham & Yaffa (PRNewsfoto/Domnick Cunningham & Yaffa)

      News provided by

      Rafferty Domnick Cunningham & Yaffa

      Jun 10, 2025, 09:25 ET

      Share this article

      Share this article


      PALM BEACH GARDENS, Fla., June 10, 2025 /PRNewswire/ -- In a new opinion piece released today as a public statement, prominent Florida trial attorney Sean C. Domnick is calling out private equity and corporate power in health care, arguing that the business of medicine has overtaken the mission of healing. From Florida to Texas to Oregon, Domnick chronicles how profit-driven motives are degrading patient care—and why courtroom accountability is now the last meaningful line of defense.

      The full op-ed, titled "Wall Street Is Practicing Medicine—And Patients Are Paying the Price," is included in its entirety below. Please contact us if you would like to interview Attorney Domnick on this issue.

      Wall Street Is Practicing Medicine—And Patients Are Paying the Price

      By Sean C. Domnick

      Every so often, we catch a fleeting glimpse of who's really calling the shots in American health care—not your doctor, not your insurer, and certainly not you. Behind the exam room curtain and beyond the hospital billing department, private equity firms and corporate conglomerates are actually pulling the strings. And sometimes, when they get sloppy, we get a rare look behind the curtain and see just how deep the rot goes.

      Let's start in Florida, where Centene—the nation's largest Medicaid managed care organization—was forced to pay over $1 billion in settlements for profiting off drug rebate kickbacks not just in Florida but in over 20 states. Instead of all that money going back to the taxpayers and patients who were shortchanged, $10 million of it was quietly funneled to a "charitable foundation" tied to the Florida governor's wife. It's the political equivalent of finding a turtle on a fencepost—you know it didn't get there by itself.

      Over in Texas, lawmakers were stunned to learn that Centene's subsidiary, Superior HealthPlan, hired private investigators to dig into their personal lives. Why? Presumably to keep those same lawmakers in line while Centene clung to its highly lucrative Medicaid contract. But it gets worse: Superior's hired guns also "investigated" Medicaid patients with disabilities—people whose complex medical needs make them expensive to care for and, therefore, a threat to the bottom line. If those invasions of privacy delayed or denied essential care, the resulting harm can't be undone. But don't worry—Texas's impeached, oft-indicted Attorney General (now running for U.S. Senate) has launched an investigation.

      This is not an isolated story. Across Florida, California, and Colorado, we've interviewed doctors being strong-armed by private equity firms—often in league with major health plans—into selling their practices for pennies on the dollar. Their tactics would make the Mob blush: sign here or we'll cut off your referrals, cancel your contracts, and bury your practice in red tape.

      Meanwhile, Steward Health Care—one of the largest for-profit hospital systems in the country—filed for bankruptcy, stiffing over 100,000 creditors on $9 billion in unpaid bills. While the patients and providers left behind scramble to pick up the pieces, Steward's real estate partners reportedly tripled their investment. The CEO? He walked away with $8 million, making him possibly the highest-paid executive in Alabama. You can't make this stuff up. Actually, you don't have to—just ask the Organized Crime and Corruption Reporting Project.

      I believe that allowing private equity to play a central role in our healthcare system puts lives at risk. A year-long investigation by Mother Jones supports this thesis, having uncovered 468 lawsuits linked to wrongful death, malpractice, and personal injury at Steward hospitals. As trial lawyers, we know that number barely scratches the surface—most patients harmed in these facilities never get their day in court. They're too poor, too intimidated, or simply too exhausted to take on billion-dollar behemoths in a legal system that was never built for them.

      In the immortal words of Casablanca, we are "shocked, shocked to find that gambling is going on in here!"

      But let's be honest—we're not shocked. We've been here before, in quiet hospital rooms where families whisper around machines, wondering if the delay in treatment cost them a loved one. We've held the hands of patients who were denied care not because it wasn't needed, but because it wasn't profitable. We've seen the kind of suffering that doesn't make headlines—only lawsuits, if the victims are lucky enough to find a lawyer who'll take the case.

      This isn't bad luck or bureaucratic error. It's a functional business model.

      What happened with Centene is just one tile in a much larger mosaic—a picture of a health care system increasingly built to serve investors, not patients. These companies don't just buy hospitals and health plans. They buy silence. They buy influence. And when money doesn't work, intimidation does. If they can't own you, they'll investigate you. If they can't threaten your livelihood, they'll dig through your past.

      Is it fair to say that no one gets the gravity of what's going on here? As The Wall Street Journal reported in May, an Oregon bill aiming to impose the nation's toughest restrictions on private equity control of healthcare practices is headed to the governor's desk, signaling a rare but significant pushback against corporate influence in medicine.

      Yet in Texas, Florida, and the nation writ large, the system is rigged for shareholders and the last place left for accountability is the courthouse. The courthouse is the last stand. It's where you can still fight back. It's where class actions and mass tort lawsuits can shine light where regulators have chosen to look away.

      Because if we don't push back now—literally and exactly now—the question isn't who will control your health care, it's who will survive it.

      About Sean C. Domnick
      Sean C. Domnick is a Shareholder at Rafferty Domnick Cunningham & Yaffa, a preeminent national boutique law firm based in Palm Beach Gardens and Pensacola, Florida.

      Press Contact:
      Natasha Diemer
      Chief Strategy Officer (CSO)
      Rafferty Domnick Cunningham & Yaffa
      Phone: (561) 516-5168
      Email: [email protected]

      Agency Contact:
      Bridget Mercuri
      Media Strategist
      AMPLIFY
      Phone: (908) 612-3515
      Email: [email protected]

      SOURCE Rafferty Domnick Cunningham & Yaffa

      Modal title

      Also from this source

      RDCY Partner Matthew Christ Featured in The Washington Post on Landmark Maryland Fire Safety Advocacy Case

      RDCY Partner Matthew Christ Featured in The Washington Post on Landmark Maryland Fire Safety Advocacy Case

      Rafferty Domnick Cunningham & Yaffa (RDCY) announces that partner, Matthew Christ was featured in The Washington Post for his role in a high-profile...

      Rafferty Domnick Cunningham & Yaffa Represents Plaintiffs in Newly Created Roblox Child Exploitation MDL

      Rafferty Domnick Cunningham & Yaffa Represents Plaintiffs in Newly Created Roblox Child Exploitation MDL

      Rafferty Domnick Cunningham & Yaffa (RDCY) is representing plaintiffs in federal lawsuits alleging that Roblox knowingly facilitated child sexual...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Advocacy Group Opinion

      Advocacy Group Opinion

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.